Revolutionary change in cancer care at AIIMS Bhopal dailypioneer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypioneer.com Daily Mail and Mail on Sunday newspapers.
G1 Therapeutics (NASDAQ:GTHX) Earns Buy Rating from Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
G1 Therapeutics, Inc. (NASDAQ:GTHX – Free Report) – Investment analysts at HC Wainwright reduced their FY2026 earnings estimates for shares of G1 Therapeutics in a research report issued to clients and investors on Thursday, May 2nd. HC Wainwright analyst E. White now expects that the company will post earnings of $0.72 per share for the […]
Needham & Company LLC reiterated their buy rating on shares of G1 Therapeutics (NASDAQ:GTHX – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $12.00 target price on the stock. Separately, Wedbush reissued an outperform rating and set a $5.00 target price (up previously from $4.00) on shares […]
G1 Therapeutics (NASDAQ:GTHX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research note issued on Wednesday, Benzinga reports. They presently have a $12.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 214.96% from […]
abrdn plc bought a new position in G1 Therapeutics, Inc. (NASDAQ:GTHX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 423,869 shares of the company’s stock, valued at approximately $1,293,000. abrdn plc owned about 0.82% of G1 Therapeutics at the end […]
abrdn plc acquired a new stake in G1 Therapeutics, Inc. (NASDAQ:GTHX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 423,869 shares of the company’s stock, valued at approximately $1,293,000. Several other institutional investors and hedge funds have also recently modified […]
G1 Therapeutics (GTHX) Set to Announce Earnings on Wednesday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
India Today Group honours Sikh Businesspersons from J&K dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.
Wedbush reaffirmed their outperform rating on shares of G1 Therapeutics (NASDAQ:GTHX – Free Report) in a research report released on Wednesday morning, RTT News reports. Wedbush currently has a $5.00 price objective on the stock, up from their previous price objective of $4.00. Separately, Needham & Company LLC reissued a buy rating and issued a […]